In vitro assay identifying cisplatin resistance of head and neck squamous cell carcinoma
Saved in:
| Main Authors: | Shu-Jen Chiang, Po-Hang Tseng, Mei-Chun Lin, Chih-Yu Leu, Chen-Yuan Dong, Pei-Jen Lou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-09-01
|
| Series: | Oral Oncology Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772906023000432 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ROLE OF GENETIC VARIABILITY IN METABOLIC PATHWAYS ON CISPLATIN-INDUCED KIDNEY INJURY IN HEAD AND NECK CANCER PATIENTS
by: Ericka Francislaine Dias Costa, et al.
Published: (2025-05-01) -
Research on interference factors of assays of SOD activity and isoenzyme
by: HU Jia-shu, et al.
Published: (2002-03-01) -
MTMR6 downregulation contributes to cisplatin resistance in oral squamous cell carcinoma
by: Kah Young Lee, et al.
Published: (2025-01-01) -
Mass spectrometry-based proteomic analysis to characterize cisplatin induced early signaling events in head and neck squamous cell carcinoma
by: Ankit P. Jain, et al.
Published: (2024-12-01) -
The role of genetic variants in the prediction of hearing loss due to cisplatin chemoradiotherapy
by: Charlotte W. Duinkerken, et al.
Published: (2024-08-01)